ACUS Acusphere, Inc.
Acusphere, Inc. (Acusphere) is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its porous microparticle technology. Acusphere is focused on developing drugs that can offer significant benefits over existing drugs, including improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. The Company's three product candidates, for which it has clinical data, are designed to address large unmet clinical needs in the areas of cardiology, oncology and asthma. Acusphere's lead product candidate, AI-700, is an ultrasound contrast agent in Phase III clinical development for the detection of coronary heart disease.
Stock history for ACUS Acusphere, Inc.
Acusphere, Inc. Announces Resignation of Richard Walovitch (Business Wire)WATERTOWN, Mass.----Acusphere, Inc. today announced that Dr. Richard Walovitch, Senior Vice President of Clinical Research, has resigned to pursue another opportunity. His resignation, effective January 9, 2009, follows an 11 year career with Acusphere, in which he oversaw the Companyâs clinical trials for its lead product candidate, ImagifyTM for Injectable Suspension, a cardiovascular drug for the detection of coronary artery disease, which addresses a potential $2 billion U.S. marketplace.
Read 
FDA cites safety concerns with Acusphere drug (AP)Shares of Acusphere plummeted Monday after federal regulators raised serious safety concerns about an imaging drug the company has touted as a potential blockbuster product.
Read
FDA panel pans Acusphere heart-imaging drug (AP)Federal advisers said Wednesday the risks of an imaging drug made by Acusphere, including abnormally low blood pressure, outweigh any advantages it has over older products.
Read
Acusphere, Inc. Announces Posting of Briefing Documents for FDA Cardio Renal Drugs Advisory Committee Meeting on Imagify (Business Wire) Read
ACUSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat (EDGAR Online) Read
ACUSPHERE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online) Read
ACUSPHERE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online) Read
ACUSPHERE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online) Read
Finance news provided by Yahoo! Finance.
